BVF: Summary for BIOVAIL CORP - Yahoo! Canada Finance - Share Prices, Charts, News and more

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 2:43pm EST - Canadian Markets close in 1 hour and 17 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Biovail Corporation (BVF)

At 14:27 EST: 14.4221 USD

0.1921 (1.35%)

MORE ON BVF

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BIOVAIL CORP (NYSE:BVF) Delayed quote data

Last Trade:	14.4221 USD
Trade Time:	2:27PM EST
Change:	0.1921 (1.35%)
Prev Close:	14.23
Open:	14.33
Bid:	N/A
Ask:	N/A
1y Target Est:	16.00

Day's Range:	14.28 - 14.48
52wk Range:	7.88 - 15.50
Volume:	225,675
Avg Vol (3m):	1,371,310
Market Cap:	2.28B
P/E (ttm):	10.21
EPS (ttm):	1.413
Div & Yield:	0.93 (6.54%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add BVF to Portfolio

Download Data

HEADLINES

•	Biovail to Participate at Upcoming Conferences
	Business Wire (Tue, Nov 10)

•	New Star Analyst Rankings for BIOVAIL CORP
	StarMine (Sun, Nov 8)

•	UPDATE - Biovail profit dips but hunt for deals continues
	at Reuters (Thu, Nov 5)

•	Biovail 3Q profit falls 17 percent on costs
	AP (Thu, Nov 5)

•	Biovail Corporation Earnings Call scheduled for 8:30 am ET today
	CCBN (Thu, Nov 5)

•	Q3 2009 Biovail Corporation Earnings Release - Time Not Supplied
	CCBN (Thu, Nov 5)

•	Biovail Reports Third-Quarter 2009 Financial Results
	Business Wire (Thu, Nov 5)

•	Biovail Declares Quarterly Dividend
	Business Wire (Thu, Nov 5)

•	Biovail Announces Third-Quarter 2009 Earnings Release, Conference-Call Details
	Business Wire (Fri, Oct 23)

•	Biovail Enters Oversold Territory
	Zacks.com (Thu, Oct 22)

•	Zacks #1 Rank Additions for Thursday
	Zacks.com (Thu, Oct 22)

•	A Dream ADR Portfolio
	at Investopedia (Wed, Oct 21)

More Headlines for BVF...

ANALYST

EPS Est (next year) (Dec-09) :	1.36
EPS Est (in 2 years) (Dec-10) :	1.42
Avg Rec (current)*:	1.9
PEG Ratio:	1.39

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Biovail Corporation, a pharmaceutical company, engages in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products principally in the United States and Canada.

Full Company Profile

Add to Portfolio

Email to a Friend

•